Please provide your email address to receive an email when new articles are posted on . LipiFlow has consistently demonstrated safety and efficacy in treating meibomian gland dysfunction. The review ...
SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative ...
Please provide your email address to receive an email when new articles are posted on . Eyes that received LipiFlow treatment before cataract surgery had improved meibomian gland scores compared with ...
SANTA ANA, Calif., Feb. 5, 2018 /PRNewswire/ -- Johnson & Johnson Vision announced today the simultaneous publication of two studies in Clinical Ophthalmology demonstrating the patient and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results